# Edesa Biotech, Inc.: Form 8-K, filed Feb 24, 2026

- Company: [Edesa Biotech, Inc.](/companies/edsa.md) (CIK 1540159)
- Form: 8-K
- Filed: 2026-02-24
- Accepted by EDGAR: Feb 24, 2026, 09:21 ET
- Period: 2026-02-24
- Accession: 0001171843-26-001046
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1540159/000117184326001046/f8k_021926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1540159/000117184326001046/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1540159/000117184326001046/f8k_021926.htm

Filed Feb 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-001046. Last ingested by Listed: Oct 29, 2026, 17:02 ET. No prices; not investment advice.